WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?

After several days and sleepless nights, members of the World Trade Organisation (WTO) finally agreed several key trade initiatives last week, including one that promises to suspend patent protection of the COVID-19 vaccines.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Careers

White & Case life sciences co-leader moves firms

2 September 2026 The senior transactions specialist brings experience advising pharmaceutical, biotechnology and technology companies on strategic alliances, licensing, M&A and cross-border transactions.

Careers

‘Busiest’ US district patent judge swaps bench for private practice

2 September 2026 One of the country's most prominent patent judges has joined A&O Shearman after nearly eight years on the federal bench.

Biotech

Exelixis locks down cancer drug exclusivity until 2030 with Fed Circ win

1 September 2026 Judges dismissed an appeal from MSN Laboratories, which was hoping to show that several patents covering Cabometyx were invalid and would not be infringed by its generic product.

More features

The ‘Triple Point’ professional: Why patent success requires science, law, and technology

The UPC plugs another gap in its procedural rulebook

Pharmascience v Janssen: Canada court updates methods of medical treatment protection

Arbutus takes Comirnaty LNP patent fight to Canada and UPC

Sanofi launches mRNA vaccine lawsuits at Moderna and Pfizer

BioNTech and Pfizer secure big European win over mRNA patent

Pfizer’s US Paxlovid patent fight turns on a single error

GLP-1 patents and Africa: The COVID-19 lessons we still have not learned

WTO's COVID deal: more vaccine ‘enabler’ than IP waiver?

More on this story

Editor's picks

Editor's picks

More features